Trinity Biotech (TRIB) Finished Goods (2016 - 2025)
Trinity Biotech (TRIB) posted Finished Goods of $3.6 million for Q4 2025, down 17.18% sequentially from $4.4 million in Q4 2024, and down 17.18% YoY from $4.4 million in Q4 2024.
Trinity Biotech (TRIB) Finished Goods (2016 - 2025) Analysis & Trends
Trinity Biotech has reported Finished Goods for 7 years, with the latest figure at $3.6 million in Q4 2025.
- Quarterly Finished Goods fell 17.18% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (down 17.18% YoY) and the FY2025 annual result came in at $3.6 million, down 17.18% from the prior year.
- Finished Goods retreated to $3.6 million in Q4 2025 per TRIB's latest filing, from $4.4 million in the prior quarter.
- Over five years, Finished Goods peaked at $4.4 million in Q4 2024 and troughed at $3.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Dec 31, 2020 | 12.88 Mn |
| Dec 31, 2019 | 12.43 Mn |
| Dec 31, 2018 | 11.56 Mn |
| Dec 31, 2017 | 15.22 Mn |
| Dec 31, 2016 | 16.13 Mn |